Market cap
$6,524 Mln
Revenue (TTM)
$2,590 Mln
P/E Ratio
40.6
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$696 Mln
-
ROE
0 %
-
ROCE
9 %
-
Industry P/E
44.07
-
EV/EBITDA
15.1
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$6.1
-
Face value
--
-
Shares outstanding
21,700,560
10 Years Aggregate
CFO
$3,324.47 Mln
EBITDA
$4,405.61 Mln
Net Profit
$6,268.10 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories Inc. Class A (BIO)
| -18.7 | -14.5 | -4.0 | -2.7 | -12.9 | -16.1 | 5.6 |
|
BSE Sensex
| -11.0 | -1.9 | -8.7 | -7.1 | 6.7 | 9.1 | 11.5 |
|
S&P Midcap 400
| 9.6 | 4.1 | 3.8 | 20.3 | 14.7 | 6.9 | 9.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories Inc. Class A (BIO)
| -7.8 | 1.7 | -23.2 | -44.3 | 29.6 | 57.5 | 59.3 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bio-Rad Laboratories Inc. Class A (BIO)
|
246.3 | 6,524.2 | 2,589.9 | 168.8 | 21.4 | 2.5 | 40.6 | 1.0 |
| 84.8 | 143,804.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 23.1 | 2.8 | |
| 17.7 | 9,053.7 | 11,320.0 | -1,098.0 | -2.0 | -16.5 | -- | 1.5 | |
| 76.2 | 10,408.9 | 3,100.6 | 586.7 | 14.2 | 12.9 | 17.9 | 2.2 | |
| 71.4 | 7,859.1 | 13,384.0 | 395.0 | 5.2 | 11.2 | 20.8 | 2.5 | |
| 150.6 | 10,678.5 | 2,900.9 | 302.8 | 15.9 | 22.5 | 35.9 | 8.2 | |
| 433.6 | 148,769.7 | 10,582.1 | 2,979.1 | 22.4 | 17.2 | 51 | 9.1 | |
| 25.7 | 25,447.4 | 17,706.2 | 972.5 | 8.7 | 8.8 | 22.7 | 1.9 | |
| 131.5 | 5,742.7 | 2,811.2 | -1,008.8 | -7.9 | -29.2 | 2162 | 1.9 | |
| 453.5 | 168,195.9 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 24.9 | 3.3 |
Shareholding Pattern
View DetailsAbout Bio-Rad Laboratories Inc. Class A (BIO)
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science... and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 Read more
-
Chairman, CEO, President & Principal Financial Officer
Mr. Norman D. Schwartz
-
Chairman, CEO & President
Mr. Norman D. Schwartz
-
Headquarters
Hercules, CA
-
Website
FAQs for Bio-Rad Laboratories Inc. Class A (BIO)
What is the current share price of Bio-Rad Laboratories Inc Class A (BIO) Today?
The share price of Bio-Rad Laboratories Inc Class A (BIO) is $246.34 (NYSE) as of 14-May-2026 10:47 EDT. Bio-Rad Laboratories Inc Class A (BIO) has given a return of -12.88% in the last 3 years.
What is the current PB & PE ratio of Bio-Rad Laboratories Inc Class A (BIO)?
The P/E ratio of Bio-Rad Laboratories Inc Class A (BIO) is 40.63 times as on 12-May-2026, a 8 discount to its peers’ median range of 44.07 times.
The P/B ratio of Bio-Rad Laboratories Inc Class A (BIO) is 0.99 times as on 12-May-2026, a 66 discount to its peers’ median range of 2.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
10.77
|
1.10
|
|
2024
|
-4.99
|
1.40
|
|
2023
|
-14.60
|
1.06
|
|
2022
|
-3.45
|
1.30
|
|
2021
|
5.31
|
1.65
|
What is the 52 Week High and Low of Bio-Rad Laboratories Inc Class A (BIO)?
The 52-week high and low of Bio-Rad Laboratories Inc Class A (BIO) are Rs 343.12 and Rs 211.43 as of 14-May-2026.
What is the market cap of Bio-Rad Laboratories Inc Class A (BIO)?
Bio-Rad Laboratories Inc Class A (BIO) has a market capitalisation of $ 6,524 Mln as on 12-May-2026. As per SEBI classification, it is a Mid Cap company.
Should I invest in Bio-Rad Laboratories Inc Class A (BIO)?
Before investing in Bio-Rad Laboratories Inc Class A (BIO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.